Literature DB >> 16537231

Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile.

Gary Donohoe1, Aiden Corvin, Ian H Robertson.   

Abstract

INTRODUCTION: Although deficits in executive functioning in schizophrenia have been consistently reported, their precise relationship to symptomatology remains unclear. Recent approaches to executive functioning in nonschizophrenia studies have aimed to "fractionate" the individual cognitive processes involved. In this study, we hypothesised that if these processes are fractionable, then particular symptom syndromes may be selectively related to executive deficits. In particular, it was hoped that this approach could clarify whether negative and positive symptoms of schizophrenia are differentially related to particular aspects of executive/attentional functions.
METHODS: A total of 32 patients with schizophrenia and 16 matched controls were assessed on a series of tasks designed to tap the theoretically derived executive functions of Inhibition, Shifting set, Working memory, and Sustained attention.
RESULTS: Negative symptoms were significantly predicted by performance on an "Inhibition" task (Stroop), and not by performance on any other task. Furthermore, for a subgroup of patients with predominantly negative symptoms variance in positive symptoms was only significantly predicted by performance on a set-shifting task (Visual Elevator), and not by performance on other tasks, including inhibition.
CONCLUSIONS: Our results support the contention that negative symptoms can, at least partly, be conceived of as cognitive behaviours expressing specific executive deficits. Specifically, we discuss the possibility that negative symptoms may, in part, express a failure in response monitoring. We further suggest that the disordered metacognition resulting in positive symptoms may be mediated by cognitive flexibility in patients with a predominantly negative symptom profile.

Entities:  

Mesh:

Year:  2006        PMID: 16537231     DOI: 10.1080/13546800444000155

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  7 in total

1.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

2.  Heterogeneity of auditory verbal working memory in schizophrenia.

Authors:  Gerard E Bruder; Daniel M Alschuler; Christopher J Kroppmann; Shiva Fekri; Roberto B Gil; Lars F Jarskog; Jill M Harkavy-Friedman; Raymond Goetz; Jürgen Kayser; Bruce E Wexler
Journal:  J Abnorm Psychol       Date:  2011-02

3.  Behavioral disinhibition: liability for externalizing spectrum disorders and its genetic and environmental relation to response inhibition across adolescence.

Authors:  Susan E Young; Naomi P Friedman; Akira Miyake; Erik G Willcutt; Robin P Corley; Brett C Haberstick; John K Hewitt
Journal:  J Abnorm Psychol       Date:  2009-02

4.  Impaired modulation of attention and emotion in schizophrenia.

Authors:  Gabriel S Dichter; Carolyn Bellion; Michael Casp; Aysenil Belger
Journal:  Schizophr Bull       Date:  2008-10-08       Impact factor: 9.306

5.  The cognitive atlas: toward a knowledge foundation for cognitive neuroscience.

Authors:  Russell A Poldrack; Aniket Kittur; Donald Kalar; Eric Miller; Christian Seppa; Yolanda Gil; D Stott Parker; Fred W Sabb; Robert M Bilder
Journal:  Front Neuroinform       Date:  2011-09-06       Impact factor: 4.081

6.  Deficient grip force control in schizophrenia: behavioral and modeling evidence for altered motor inhibition and motor noise.

Authors:  Maxime Teremetz; Isabelle Amado; Narjes Bendjemaa; Marie-Odile Krebs; Pavel G Lindberg; Marc A Maier
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

7.  Developmental trajectories of executive functions in 22q11.2 deletion syndrome.

Authors:  Johanna Maeder; Maude Schneider; Mathilde Bostelmann; Martin Debbané; Bronwyn Glaser; Sarah Menghetti; Marie Schaer; Stephan Eliez
Journal:  J Neurodev Disord       Date:  2016-03-25       Impact factor: 4.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.